The RELIEV-CM2 Clinical Study for Chronic Migraine
Learn more about the RELIEV–CM2 clinical study at Neurovations Research evaluating a new implantable medical device used as a potential treatment to prevent and relieve migraine symptoms.
Learn more about the RELIEV–CM2 clinical study at Neurovations Research evaluating a new implantable medical device used as a potential treatment to prevent and relieve migraine symptoms.
26th Annual Selby Spine Conference The Selby Spine Conference addresses the latest advances and controversies in the field of spine surgery. Through didactic lectures, interactive panel discussions, case-based presentations, and debates, the faculty will share their insights on such issues as complex spone surgery, treatment options for lumbar pathology, avoiding surgical complications, cervical spine surgery, […]
CEO and Founder of Neurovations Dr. Eric Grigsby Celebrates Three Decades of Innovation in Chronic Pain Management at 30th Napa Pain Conference NAPA, Calif., September 12, 2023 (Newswire.com) – The 30th Napa Pain Conference concluded on Aug. 20, 2023, celebrating three decades of unwavering commitment to advancing treatments and research for pain and neurological disease. The […]
NAPA, Calif., Sept. 28, 2022 /PRNewswire/ — Neurovations now offers transcranial magnetic stimulation (TMS) for the treatment of Major Depressive Disorder (MDD) — making it the first mental health provider of TMS Therapy in Napa Valley where mental health services are in high demand. TMS is used to activate areas of the brain that are underactive in depression. The addition of […]
Dr Eric Grigsby, CEO and Founder, Neurovations September is Pain Awareness Month. We want to raise awareness and provide resources for physicians and patients alike. Follow us this month for complimentary webinars, keynotes from the Napa Pain Conference and more. #painmanagement #physiotherapy #chronicillnes Facebook Twitter Linked In Instagram Youtube The post Pain Awareness Month appeared […]
The COVID-19 pandemic has highlighted a need for non-invasive, remote approaches to patient care. Dr. Eric Grigsby, CEO and Founder of Neurovations, and Ana Maiques, CEO and Co-founder of Neuroelectrics, met to discuss new ways to treat brain diseases at home. Learn how companies like Neuroelectrics are working to bring non-invasive brain stimulation into the home.
What does it really take to get that big idea to market? Entrepreneurs Eric Grigsby, MD, MBA, CEO and Founder of Neurovations, and David Caraway, MD PhD, CMO from Nevro discussed some of the fundamentals to launch a new idea.
CEO and Founder of Neurovations, Dr. Eric Grigsby, and Co-founder and Director of Research at Millennium Pain Center, Dr. Ricardo Vallejo joined up for a deep dive into how a hypothesis can change the way we think about SCS therapies and optimizing outcomes. Dr. Vallejo unpacked the questions necessary to get to a truer understanding […]
CEO and Founder of Neurovations Dr. Eric Grigsby and Chief Medical Officer of Setpoint Dr. David Chernoff met for an in-depth discussion on the activation of neuroimmune reflexes by Vagus Nerve Stimulation which reduced disease activity in a proof-of-concept study in Rheumatoid Arthritis. Watch the Video
CEO and Founder of Neurovations, Dr. Eric Grigsby joined Professor and Director of Neuromodulation Services at UCSF, Dr. Lawrence Poree, for an in-depth conversation on equity and inclusion in pain management.
CEO and Founder of Neurovations and Eric J. Grigsby, MD, MBA and Peter Staats, MD, MBA met recently for a conversation exploring Neuromodulation for the COVID-19 Cytokine Storm.
Dr. Ruben Kalra recently joined the founder and CEO of Neurovations, Dr. Eric Grigsby to share timely and relevant tips on how to stay afloat as an independent medical practice during COVID-19. “The Fight for Survival” focused on telehealth strategies for patient and practice reimbursement and included the prudent monitoring of patients at risk of […]